Historical record - last NADAC effective date: 2/22/2023

Product Information

OLMESARTAN MEDOXOMIL 20 MG TAB is a generic product labeled by Lifestar Pharma LLC, priced at $0.0888 per EA under NDC 70756080930. Its NADAC has been published 133 times since Aug 12, 2020.

FDA first approved this application on Jul 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the OLMESARTAN MEDOXOMIL market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OLMESARTAN MEDOXOMIL 20 MG TAB

OLMESARTAN MEDOXOMIL
$0.0888per EA
High Outlier

Strength

20 mg/1

NDC

70756080930

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/22/2023

Active Ingredients

OLMESARTAN MEDOXOMIL

Approval Type

Generic (ANDA)

FDA Application

ANDA207135

FDA Approved

7/18/2019

TE Code

AB

On Market Since

5/1/2020

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker

Price Statistics

The NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has been published 133 times since Aug 12, 2020, and over the history we have for it it has declined 24.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0888 per EA
All-time high$0.1402 (Feb 10, 2021)
All-time low$0.0845 (Dec 21, 2022)
Median price$0.1150
Average price$0.1103
Largest weekly change+25.6% (Jan 20, 2021)
Weeks tracked133
Tracking sinceAug 12, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

-33.9%

All

-24.6%

Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLMESARTAN MEDOXOMIL 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN MEDOXOMIL 20 MG TAB, manufactured by Lifestar Pharma LLC, is $0.0888 per EA (NDC 70756080930), effective Feb 22, 2023.

How has the price of OLMESARTAN MEDOXOMIL 20 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has declined 24.6%. It has been tracked across 133 weekly CMS publications since Aug 12, 2020.

What are the highest and lowest recorded NADAC prices for OLMESARTAN MEDOXOMIL 20 MG TAB?

Since Aug 12, 2020, the NADAC for OLMESARTAN MEDOXOMIL 20 MG TAB has ranged from a low of $0.0845 (Dec 21, 2022) to a high of $0.1402 (Feb 10, 2021), with a median of $0.1150 per EA.

Are there cheaper alternatives to OLMESARTAN MEDOXOMIL 20 MG TAB?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OLMESARTAN MEDOXOMIL 20 MG TAB, is $0.0810 per EA — about 9% below OLMESARTAN MEDOXOMIL 20 MG TAB.

Who manufactures OLMESARTAN MEDOXOMIL 20 MG TAB?

OLMESARTAN MEDOXOMIL 20 MG TAB (NDC 70756080930) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.